abstract |
The present invention provides a method for inhibiting cancer, which comprises activating a p53 cancer suppressor gene or p53 protein and localizing it in the nucleus, and a pharmaceutical composition containing a substance that promotes the activity of the p53 cancer suppressor gene or p53 protein. |